Company: INTS
Filing Date: 2025-12-04
Form Type: 8-K
Source: 0001567264-25-000109
Chunk: 1

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-12-04
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01. Financial Statements and Exhibits

(d) Exhibits

  Exhibit No.      Description                                                                                 
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────
          5.1      Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C.                             
         23.1      Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C. (included in Exhibit 5.1).  
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              Intensity Therapeutics, Inc.                               
  Date: December 4, 2025      By:                               /s/ Lewis H. Bender      
                                                                Lewis H. Bender          
                                                                Chief Executive Officer